Clinical Trial Update: An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 ascending-dose study of KW-2449 in patients with acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, and chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• KW-2449 (KW-2449)

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Status: TERMINATED | Results posted: 2016-08-12